Please login to the form below

Not currently logged in
Email:
Password:

Cristal Therapeutics names chief business officer

Neuroscientist Jeroen Tonnaer to take up the position

edit-Cristal-TherapeuticsLife sciences firm Cristal Therapeutics has named Jeroen Tonnaer as its chief business officer.

Tonnaer joins from Merck Sharp & Dohme, where he was executive director, head European external scientific affairs and worldwide licensing. He will be responsible for the company's business development, partnering and licensing activities.

As a neuroscientist, Tonnaer has expansive experience in the sector, including senior positions such as head of discovery collaborations Europe and Schering-Plough and head of the department of drug metabolism and kinetics at Organon.

He additionally serves as founder and executive consultant for PharmProspect, which helps start-ups and biotech companies work with pharma.

Joost Holthuis, CEO at Cristal Therapeutics, commented: “I am delighted to welcome Jeroen to Cristal Therapeutics and look forward to working with him.

“Jeroen will strengthen our key existing business relationships and focus on finding, executing and fostering new partnering opportunities for Cristal Therapeutics.

Cristal Therapeutics works with a focus on developing novel nanotherapeutics against cancer and other diseases by using its CriPec platform.

27th April 2015

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics